Engineered synthase for production of tryptophan derivatives and intransigent substrates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing tryptophan analogs and non-canonical amino acids using tryptophan synthase are limited by low substrate concentrations, low yields, and poor thermostability, particularly in the S. typhimurium TrpS complex, which complicates efforts to engineer activity, substrate specificity, and stability.
Innovation Solution
Development of modified β-subunits of tryptophan synthase with specific mutations that stabilize the closed state, enabling the production of tryptophan analogs and non-canonical amino acids, even with electron-withdrawing groups, using serine and indole analogs as substrates, in both recombinant cells and cell-free systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the wild-type tryptophan synthase complex is used, then the enzyme catalyzes the formation of L-tryptophan from L-serine and indole glycerol phosphate, but the substrate concentration is limited and the yield is low
Solution Approach 1:
The patent applies parameter changes by introducing specific mutations (e.g., E104G, E104A, M139L, N166D) in the β-subunit of tryptophan synthase to alter the enzyme's kinetic parameters. These mutations modify the active site geometry and substrate binding affinity, enabling the enzyme to process a broader range of substrates including indole analogs with electron-withdrawing groups at higher concentrations while maintaining high yield production of tryptophan derivatives.
Solution Approach 2:
The patent applies local quality by making targeted modifications specifically in the β-subunit's active site region while maintaining the overall heterodimeric complex structure. The mutations are localized to specific residues (positions 104, 139, 166, 183, 186, 212, 274, 292, 321, 384) that directly interact with substrates, allowing enhanced catalytic efficiency for specific substrate classes without affecting the global enzyme architecture.
2Reliability
If the S. typhimurium TrpS complex is used, then the enzyme catalyzes tryptophan formation, but the thermostability is poor
Solution Approach 1:
The patent applies parameter changes by introducing mutations that alter the thermal stability parameters of the enzyme. Specific mutations such as M139L, N166D, and others modify the structural rigidity and hydrophobic core packing of the β-subunit, enabling the enzyme to maintain structural integrity and catalytic activity at elevated temperatures, thereby improving thermostability for industrial applications.
3Productivity
If isolated enzyme subunits are used, then the metabolic load on the host cell is reduced, but the catalytic efficiency is much lower when isolated
Solution Approach 1:
The patent applies segmentation by separating the catalytic function into the isolated β-subunit while maintaining the heterodimeric complex architecture. The β-subunit contains the active site for indole analog reactions, and by expressing only this subunit in host cells, the metabolic load is reduced compared to expressing the complete tryptophan synthase complex, while still achieving high catalytic efficiency through the engineered active site.
Solution Approach 2:
The patent applies the extraction principle by isolating and engineering the β-subunit as a standalone catalytic unit. The β-subunit is extracted from the full heterodimeric complex and engineered with specific mutations to achieve high catalytic efficiency independently, thereby reducing the metabolic burden on host cells while maintaining productive catalysis for tryptophan derivative synthesis.
4Adaptability or versatility
If the enzyme is engineered for activity and substrate specificity, then the production of tryptophan analogs is improved, but the stability and other properties become more difficult to engineer
Solution Approach 1:
The patent applies segmentation by focusing engineering efforts on the isolated β-subunit rather than the complete heterodimeric complex. This modular approach allows targeted mutations to be introduced and stabilized in the β-subunit's active site region, achieving high substrate specificity for tryptophan analogs and non-canonical amino acids while maintaining overall structural stability through conserved regions of the subunit.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified β-subunits exhibit enhanced catalytic efficiency and stability, allowing for the production of valuable synthetic building blocks with improved yields and substrate versatility, suitable for applications in chemical biology and pharmaceuticals.
Implementation Method 1
modified β-subunits of tryptophan synthase... catalyzes the production of tryptophan analogs... enhanced catalytic efficiency
Data Source
AI summary
This disclosure relates to modified tryptophan synthase and more particularly to modified beta-subunits of tryptophan synthase. The disclosure further relates to cells expressing such modified subunits and methods of producing non-canonical amino acids.